New device being tested at Abbott Northwestern Hospital gives hope to patients with leaking heart valve

[Star Tribune, September 6, 2019] Three tricuspid regurgitation (TR) patients at Minneapolis’ Abbott Northwestern Hospital quietly jumped to the forefront of a wave of cardiology innovation represented by a class of new “structural heart” devices that optimize blood flow using foldable memory metals and tendril-like catheters thin enough to fit inside blood vessels.

“I had a lot of pain and a lot of shortness of breath. And now that’s all kind of gone away,” said one patient seven days into a yearlong clinical trial of an unapproved device called the TriClip, designed by Abbott Laboratories in Chicago and implanted by a Minneapolis Heart Institute medical team led by Dr. Paul Sorajja.

Read the full story online at www.startribune.com.

The TriClip was designed by Abbott Laboratories in Chicago.

Get Allina in the News delivered to your email inbox each morning.